Disruption of Water Networks is the Cause of Human/Mouse Species Selectivity in Urokinase Plasminogen Activator (uPA) Inhibitors Derived from Hexamethylene Amiloride (HMA)

Journal of Medicinal Chemistry
2022.0

Abstract

The urokinase plasminogen activator (uPA) plays a critical role in tumor cell invasion and migration and is a promising antimetastasis target. 6-Substituted analogues of 5-<i>N,N</i>-(hexamethylene)amiloride (HMA) are potent and selective uPA inhibitors that lack the diuretic and antikaliuretic properties of the parent drug amiloride. However, the compounds display pronounced selectivity for human over mouse uPA, thus confounding interpretation of data from human xenograft mouse models of cancer. Here, computational and experimental findings reveal that residue 99 is a key contributor to the observed species selectivity, whereby enthalpically unfavorable expulsion of a water molecule by the 5-<i>N,N</i>-hexamethylene ring occurs when residue 99 is Tyr (as in mouse uPA). Analogue <b>7</b> lacking the 5-<i>N,N</i>-hexamethylene ring maintained similar water networks when bound to human and mouse uPA and displayed reduced selectivity, thus supporting this conclusion. The study will guide further optimization of dual-potent human/mouse uPA inhibitors from the amiloride class as antimetastasis drugs.

Knowledge Graph

Similar Paper

Disruption of Water Networks is the Cause of Human/Mouse Species Selectivity in Urokinase Plasminogen Activator (uPA) Inhibitors Derived from Hexamethylene Amiloride (HMA)
Journal of Medicinal Chemistry 2022.0
6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer
Journal of Medicinal Chemistry 2018.0
Systematic evaluation of structure–property relationships and pharmacokinetics in 6-(hetero)aryl-substituted matched pair analogs of amiloride and 5-(N,N-hexamethylene)amiloride
Bioorganic &amp; Medicinal Chemistry 2021.0
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines
Bioorganic &amp; Medicinal Chemistry Letters 2002.0
Novel Human Aminopeptidase N Inhibitors: Discovery and Optimization of Subsite Binding Interactions
Journal of Medicinal Chemistry 2019.0
Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A
MedChemComm 2018.0
Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors
European Journal of Medicinal Chemistry 2021.0
Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins
Journal of Medicinal Chemistry 2009.0
Identification of Novel Inhibitors of Urokinase via NMR-Based Screening
Journal of Medicinal Chemistry 2000.0
New Pyrrole Inhibitors of Monoamine Oxidase:  Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity
Journal of Medicinal Chemistry 2007.0